Prof Stephen Johnston speaks to ecancer in an online interview about how to manage breast cancer during the COVID-19 pandemic.

Initially, Prof Johnston discusses the implications COVID-19 has had on detection, including a significant decrease in screening and thus diagnoses.

He goes into detail about how managing patients has been adapted to deliver safe cancer treatment, including fast-forwarding some organisational procedures and more telecommunication. These have had some extra benefits but also a few drawbacks.

Prof Johnston details treatment measures for all stages of breast cancer under COVID-19, covering toxicities and co-morbidities that need to be managed.

He finalises by discussing how COVID-19 has impacted breast cancer research, and also how cancer practice will be changed permanently as the COVID crisis diminishes.

More videos in this series:

Prof Philip Poortmans (University of Antwerp, Antwerp, Belgium) - Diagnosing, treating and managing breast cancer during COVID-19

Prof Alessandra Gennari (University Hospital of Novara, Piedmont, Italy) - An oncologist's experience of managing breast cancer during the COVID-19 outbreak

Dr Javier Cortés (IOB Institute of Oncology, Madrid and Barcelona, Spain) - COVID-19 and breast cancer: How should we treat our patients?

Produced with an educational grant from Eisai Europe Limited who, other than suggesting the topic, were not involved in the review of the videos or the selection of the clinicians in this video.